A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

Neurons deep in the brain not only help to initiate movement—they also actively suppress it, and with astonishing precision. This is the conclusion of a new study by researchers at the University of ...